Efficacy of Extracorporeal Shockwave Therapy on Plantar Fasciitis in Patients With Peripheral Neuropathy

Sponsor
National Taiwan University Hospital
Study ID
NCT07587255
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Neuropathic Pain
  • Plantar Fasciitis

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Extracorporeal shockwave therapy (ESWT) — DEVICE
    Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive treatment for plantar fasciitis, using acoustic waves to stimulate healing. Participants enrolled in the study will receive real or sham ESWT.

Study Details

This study aims to evaluate the efficacy of extracorporeal shockwave therapy (ESWT) in reducing pain and improving functional outcomes for patients with neuropathy-associated plantar fasciitis.

Key Dates

First listed
May 14, 2026
Start date
May 31, 2026
Status verified
Apr 2026
Primary completion
Apr 30, 2031
Completion
May 31, 2032

Study Design

Enrollment
114 participants (estimated)
Allocation
NA
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Extracorporeal shockwave therapy (ESWT)
    Participants of the study will receive real or sham ESWT during the study period

Primary Outcome Measure

Visual analogue scale of pain [ Time Frame: VAS scores will be recorded before and after each ESWT session, as well as two weeks post-intervention. Long-term follow-up evaluations will be conducted at 12 weeks and 12 months following the final treatment. ]

Central Contacts

Related Studies